Pharmaceutical manufacturers often avoid putting new excipients in their formulations for fear of more regulatory oversight. IPEC has a solution. Jan 2, 2008 By:Christopher C. DeMerlis, Jay M. Goldring, David R. Schoneker
Pharmaceutical manufacturers often avoid putting new excipients in their formulations for fear of more regulatory oversight. IPEC has a solution.
 |
As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients. Oct 4, 2007 By:David R. Schoneker
As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients.
 |
As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients. Sep 1, 2007 By:David R. Schoneker
As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients.
 |
The results from a Product Quality Research Institute study provide insights about the decisions of excipient manufacturers and drug-product manufacturers regarding testing excipient quality and using excipients in pharmaceutical manufacturing. Sep 2, 2006 By:Gregory Larner, David R. Schoneker, Catherine Sheehan, Rajendra Uppoor, Phyllis Walsh, Robert Wiens
The Product Quality Research Institute (PQRI) conducted an open, publicly available, electronic survey of current excipient-control strategies among pharmaceutical excipient manufacturers, excipient distributors, and drug-product manufacturers (excipient users). Among the major findings are:
 |
|